SCHEDULE: ClearPoint Neuro: Ownership Update Filed

ClearPoint Neuro, Inc. has filed an amendment to its Schedule 13G, detailing updated beneficial ownership information as of June 30, 2026.

Summary

• This filing is an amendment to a Schedule 13G for ClearPoint Neuro, Inc., reporting changes in beneficial ownership.
• The reporting persons include Bigger Capital Fund LP, Bigger Capital Fund GP, LLC, District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, Michael Bigger, and Patricia Winter.
• As of August 4, 2026, the aggregate beneficial ownership reported by Michael Bigger is 7.45% of the outstanding Common Stock.
• Bigger Capital and Bigger GP collectively hold approximately 4.60% of the outstanding Common Stock.
• District 2 entities collectively hold approximately 0.96% of the outstanding Common Stock.
• Patricia Winter holds approximately 0.54% of the outstanding Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting changes in beneficial ownership without significant new strategic or financial information.

Positives

• The filing provides clarity on the beneficial ownership structure of ClearPoint Neuro, Inc.
• The reporting persons are individuals and entities based in Delaware and the United States.

Negatives

• The filing does not contain new financial results or strategic updates, only ownership information.
• The complex web of reporting entities and shared ownership claims could be confusing for some investors.

Risks

• Potential for future changes in beneficial ownership that could impact control or strategic direction.
• The filing does not provide insight into the reasons for the ownership changes.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Management Comments

• Each of Bigger GP and Mr. Bigger disclaims beneficial ownership of the shares of Common Stock beneficially owned by Bigger Capital.
• Each of District 2, District 2 GP, District 2 Holdings and Mr. Bigger disclaims beneficial ownership of the shares of Common Stock beneficially owned by District 2 CF.
• Mr. Bigger disclaims beneficial ownership of the shares held by Patricia Winter and by the sons of Mr. Bigger, and Ms. Winter disclaims beneficial ownership of the shares of Common Stock held by Mr. Bigger.
• The filing of this statement shall not be construed as an admission that any such person or entity is the beneficial owner of any such securities.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for significant institutional investors and are common in the biotechnology and medical device sectors where ClearPoint Neuro operates, indicating active investor interest.

Stakeholder Impact

• Shareholders: Increased transparency regarding major beneficial owners.
• Management: Awareness of significant shareholder positions and potential influence.

Next Steps

• Monitor future filings for any further changes in beneficial ownership.
• Observe company performance and strategic announcements for context regarding ownership shifts.

Key Dates

Keywords

ClearPoint Neuro, Schedule 13G, Beneficial Ownership, SEC Filing, Investment Funds, Stock Ownership